CMPS
COMPASS Pathways plc
Price Chart
Latest Quote
$12.53
+0.59 (+4.94%)
Current Price
| Previous Close | $11.94 |
| Open | $12.20 |
| Day High | $12.57 |
| Day Low | $11.92 |
| Volume | 3,536,431 |
Stock Information
| Shares Outstanding | 134.95M |
| Total Debt | $53.31M |
| Cash Equivalents | $466.01M |
| Net Income | $-192.36M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $1.69B |
| EPS (TTM) | $-3.14 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.14B |
| Income | $-192.36M |
| Book/sh | $2.42 |
| Cash/sh | $3.45 |
| Employees | 156 |
Financial Ratios
| Quick Ratio | 3.13 |
| Current Ratio | 3.32 |
| Debt/Eq | 16.32 |
Returns & Margins
| ROA | -25.64% |
| ROE | -68.48% |
Ownership
| Insider Ownership | 7.83% |
| Institutional Ownership | 72.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -11.86 |
| P/B | 5.18 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $22.20 |
Technical Indicators
| SMA20 | $12.15 |
| SMA50 | $10.11 |
| SMA200 | $7.19 |
| RSI | 46.55 |
| ATR | 0.9868 |
| Shares Float | 101.49M |
| Short Float | 5.50% |
| Short Ratio | 1.88 |
| Volatility | 2.51 |
| Rel Volume | 0.98 |
Performance History
| Week | +9.82% |
| Month | +24.43% |
| Quarter | +118.67% |
| 6 Months | +96.09% |
| YTD | +91.30% |
| Year | +179.69% |
| 3 Years | +54.88% |
| 5 Years | -68.42% |
| 10 Years | -56.79% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $12.53 | 3,625,300 |
| 2026-06-17 | $11.94 | 2,079,300 |
| 2026-06-16 | $11.49 | 2,055,700 |
| 2026-06-15 | $11.79 | 2,077,400 |
| 2026-06-12 | $12.08 | 2,513,000 |
| 2026-06-11 | $11.41 | 3,696,900 |
| 2026-06-10 | $11.03 | 2,159,900 |
| 2026-06-09 | $11.26 | 3,545,300 |
| 2026-06-08 | $11.73 | 3,102,300 |
| 2026-06-05 | $12.11 | 4,270,300 |
| 2026-06-04 | $13.05 | 3,532,700 |
| 2026-06-03 | $12.69 | 3,208,600 |
| 2026-06-02 | $13.33 | 5,391,600 |
| 2026-06-01 | $14.19 | 8,953,000 |
| 2026-05-29 | $13.06 | 4,557,700 |
| 2026-05-28 | $11.92 | 2,558,000 |
| 2026-05-27 | $11.85 | 2,869,700 |
| 2026-05-26 | $12.23 | 3,881,400 |
| 2026-05-22 | $11.81 | 3,865,100 |
| 2026-05-21 | $11.59 | 6,210,200 |
| 2026-05-20 | $10.87 | 3,927,700 |
| 2026-05-19 | $10.07 | 4,135,500 |
About COMPASS Pathways plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
đ° Latest News
Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T20:31:40Z
Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment?
Simply Wall St. âĸ 2026-06-02T09:13:17Z
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
MarketBeat âĸ 2026-05-21T06:03:16Z
This Psychedelics Stock Just Keeps Getting Hotter; Why Shares Bypassed A Profit-Taking Zone
Investor's Business Daily âĸ 2026-05-18T20:07:11Z
Assessing COMPASS Pathways (CMPS) Valuation After Strong Q1 2026 Earnings And Key FDA Milestones
Simply Wall St. âĸ 2026-05-15T03:15:07Z
Compass Pathways PLC (CMPS) Q1 2026 Earnings Call Highlights: Promising Advances in ...
GuruFocus.com âĸ 2026-05-13T23:02:36ZTranscript: Compass Pathways Q1 2026 Earnings Conference Call
Benzinga âĸ 2026-05-13T22:34:21Z
Here's Why This Psychedelics Stock Just Took A Trip To A Two-Year High
Investor's Business Daily âĸ 2026-05-13T20:08:18Z
Compass (CMPS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-13T18:55:22Z
Compass Pathways shares rise on Q1 results, accelerated FDA review
Proactive âĸ 2026-05-13T16:33:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $4,517,000 | $4,479,000 | $2,204,000 | $0 |
| Total Expenses | $175,290,000 | $157,108,000 | $124,044,000 | $95,979,000 |
| Other Income Expense | $-117,710,000 | $-209,000 | $3,941,000 | $4,882,000 |
| Other Non Operating Income Expenses | $1,380,000 | $823,000 | $255,000 | $4,061,000 |
| Net Non Operating Interest Income Expense | $2,665,000 | $3,789,000 | $2,419,000 | $0 |
| Interest Expense Non Operating | $4,517,000 | $4,479,000 | $2,204,000 | $0 |
| Operating Expense | $175,290,000 | $157,108,000 | $124,044,000 | $95,979,000 |
| General And Administrative Expense | $60,601,000 | $59,166,000 | $49,401,000 | $45,350,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Net Interest Income | $2,665,000 | $3,789,000 | $2,419,000 | $0 |
| Interest Income | $7,182,000 | $8,268,000 | $4,623,000 | - |
| Normalized Income | $-169,786,378 | $-154,348,000 | $-121,449,660 | $-92,170,010 |
| Net Income From Continuing And Discontinued Operation | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Total Operating Income As Reported | $-179,037,000 | $-178,205,000 | $-136,919,000 | $-110,403,000 |
| Net Income Common Stockholders | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Net Income | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Net Income Including Noncontrolling Interests | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Net Income Continuous Operations | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Pretax Income | $-290,335,000 | $-153,528,000 | $-117,684,000 | $-91,097,000 |
| Interest Income Non Operating | $7,182,000 | $8,268,000 | $4,623,000 | - |
| Operating Income | $-175,290,000 | $-157,108,000 | $-124,044,000 | $-95,979,000 |
| Per Share | ||||
| Diluted EPS | $-3.08 | $-2.30 | $-2.32 | $-2.16 |
| Basic EPS | $-3.08 | $-2.30 | $-2.32 | $-2.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,014,378 | $-258,000 | $700,340 | $155,990 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-166,512,000 | $-147,784,000 | $-118,924,000 | $-91,588,000 |
| Total Unusual Items | $-119,090,000 | $-1,032,000 | $3,686,000 | $821,000 |
| Total Unusual Items Excluding Goodwill | $-119,090,000 | $-1,032,000 | $3,686,000 | $821,000 |
| Reconciled Depreciation | $216,000 | $233,000 | $242,000 | $330,000 |
| EBITDA (Bullshit earnings) | $-285,602,000 | $-148,816,000 | $-115,238,000 | $-90,767,000 |
| EBIT | $-285,818,000 | $-149,049,000 | $-115,480,000 | $-91,097,000 |
| Diluted Average Shares | $93,504,836 | $67,482,902 | $67,482,902 | $42,436,292 |
| Basic Average Shares | $93,504,836 | $67,482,902 | $67,482,902 | $42,436,292 |
| Diluted NI Availto Com Stockholders | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Tax Provision | $-2,473,000 | $1,594,000 | $780,000 | $408,000 |
| Gain On Sale Of Security | $-119,090,000 | $-1,032,000 | $3,686,000 | $821,000 |
| Other Taxes | $-3,747,000 | $-21,097,000 | $-12,875,000 | $-14,424,000 |
| Research And Development | $118,436,000 | $119,039,000 | $87,518,000 | $65,053,000 |
| Selling General And Administration | $60,601,000 | $59,166,000 | $49,401,000 | $45,350,000 |
| Other Gand A | $32,383,000 | $26,536,000 | $22,842,000 | $22,425,000 |
| Salaries And Wages | $28,218,000 | $32,630,000 | $26,559,000 | $22,925,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-52,848,000 | $154,695,000 | $225,744,000 | $181,280,000 |
| Total Assets | $210,349,000 | $213,666,000 | $275,987,000 | $197,294,000 |
| Total Non Current Assets | $18,859,000 | $12,375,000 | $14,691,000 | $5,643,000 |
| Other Non Current Assets | $734,000 | $858,000 | $202,000 | $327,000 |
| Non Current Prepaid Assets | $0 | $5,737,000 | $5,955,000 | $0 |
| Non Current Deferred Assets | $3,751,000 | $3,774,000 | $3,336,000 | $2,224,000 |
| Non Current Deferred Taxes Assets | $3,751,000 | $3,774,000 | $3,336,000 | $2,224,000 |
| Non Current Accounts Receivable | $10,950,000 | - | - | - |
| Current Assets | $191,490,000 | $201,291,000 | $261,296,000 | $191,651,000 |
| Other Current Assets | $5,580,000 | $3,580,000 | $1,895,000 | $1,042,000 |
| Restricted Cash | $379,000 | $389,000 | $440,000 | $175,000 |
| Prepaid Assets | $20,536,000 | $11,529,000 | $9,834,000 | $31,604,000 |
| Receivables | $15,387,000 | $20,712,000 | $28,929,000 | $15,624,000 |
| Taxes Receivable | $15,387,000 | $20,712,000 | $28,929,000 | $15,624,000 |
| Cash Cash Equivalents And Short Term Investments | $149,608,000 | $165,081,000 | $220,198,000 | $143,206,000 |
| Cash And Cash Equivalents | $149,608,000 | $165,081,000 | $220,198,000 | $143,206,000 |
| Current Deferred Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $35,035,000 | $32,193,000 | $33,050,000 | $1,928,000 |
| Long Term Debt And Capital Lease Obligation | $15,402,000 | $24,955,000 | $30,639,000 | $418,000 |
| Long Term Debt | $14,110,000 | $24,652,000 | $28,757,000 | - |
| Current Debt And Capital Lease Obligation | $19,633,000 | $7,238,000 | $2,411,000 | $1,510,000 |
| Current Debt | $17,523,000 | $5,513,000 | - | - |
| Other Current Borrowings | $17,523,000 | $5,513,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $263,197,000 | $58,971,000 | $50,243,000 | $16,014,000 |
| Total Non Current Liabilities Net Minority Interest | $15,402,000 | $24,955,000 | $30,639,000 | $418,000 |
| Current Liabilities | $247,795,000 | $34,016,000 | $19,604,000 | $15,596,000 |
| Other Current Liabilities | $204,285,000 | $1,325,000 | $1,038,000 | $656,000 |
| Payables And Accrued Expenses | $18,432,000 | $17,539,000 | $9,086,000 | $7,896,000 |
| Payables | $15,222,000 | $12,283,000 | $5,892,000 | $4,928,000 |
| Accounts Payable | $15,222,000 | $12,283,000 | $5,892,000 | $4,761,000 |
| Total Tax Payable | - | $0 | $0 | $167,000 |
| Income Tax Payable | - | $0 | $0 | - |
| Equity | ||||
| Common Stock Equity | $-52,848,000 | $154,695,000 | $225,744,000 | $181,280,000 |
| Total Equity Gross Minority Interest | $-52,848,000 | $154,695,000 | $225,744,000 | $181,280,000 |
| Stockholders Equity | $-52,848,000 | $154,695,000 | $225,744,000 | $181,280,000 |
| Gains Losses Not Affecting Retained Earnings | $-14,789,000 | $-16,194,000 | $-16,926,000 | $-16,867,000 |
| Other Equity Adjustments | $-14,789,000 | $-16,194,000 | $-16,926,000 | $-16,867,000 |
| Retained Earnings | $-822,594,000 | $-534,732,000 | $-379,610,000 | $-261,146,000 |
| Other Equity Interest | - | - | - | $28,000 |
| Other | ||||
| Ordinary Shares Number | $96,085,785 | $68,552,215 | $61,943,471 | $42,631,794 |
| Share Issued | $96,085,785 | $68,552,215 | $61,943,471 | $42,631,794 |
| Tangible Book Value | $-52,848,000 | $154,695,000 | $225,744,000 | $181,280,000 |
| Invested Capital | $-21,215,000 | $184,860,000 | $254,501,000 | $181,280,000 |
| Working Capital | $-56,305,000 | $167,275,000 | $241,692,000 | $176,055,000 |
| Capital Lease Obligations | $3,402,000 | $2,028,000 | $4,293,000 | $1,928,000 |
| Total Capitalization | $-38,738,000 | $179,347,000 | $254,501,000 | $181,280,000 |
| Additional Paid In Capital | $783,562,000 | $704,919,000 | $621,645,000 | $458,825,000 |
| Capital Stock | $973,000 | $702,000 | $635,000 | $440,000 |
| Common Stock | $973,000 | $702,000 | $635,000 | $440,000 |
| Long Term Capital Lease Obligation | $1,292,000 | $303,000 | $1,882,000 | $418,000 |
| Current Capital Lease Obligation | $2,110,000 | $1,725,000 | $2,411,000 | $1,510,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,445,000 | $7,914,000 | $7,069,000 | $5,534,000 |
| Current Accrued Expenses | $3,210,000 | $5,256,000 | $3,194,000 | $2,968,000 |
| Net PPE | $3,424,000 | $2,006,000 | $4,729,000 | $2,623,000 |
| Gross PPE | $3,424,000 | $2,006,000 | $4,729,000 | $2,623,000 |
| Other Properties | $3,424,000 | $2,006,000 | $4,729,000 | $2,623,000 |
| Investments And Advances | - | $469,000 | $469,000 | $469,000 |
| Other Investments | - | $469,000 | $469,000 | $469,000 |
| Treasury Shares Number | - | - | $0 | - |
| Accumulated Depreciation | - | - | - | $-530,000 |
| Leases | - | - | - | $91,000 |
| Machinery Furniture Equipment | - | - | - | $724,000 |
| Properties | - | - | - | $0 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-157,240,000 | $-119,186,000 | $-97,442,000 | $-106,047,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-157,240,000 | $-119,186,000 | $-97,376,000 | $-105,451,000 |
| Cash Flow From Continuing Operating Activities | $-157,240,000 | $-119,186,000 | $-97,376,000 | $-105,451,000 |
| Operating Gains Losses | $121,409,000 | $755,000 | $-2,577,000 | $1,141,000 |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $-64,000 | $-596,000 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-64,000 | $-596,000 |
| Capital Expenditure | - | - | $-66,000 | $-596,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $140,357,000 | $26,219,000 | $144,935,000 | $440,000 |
| Financing Cash Flow | $140,712,000 | $63,824,000 | $173,830,000 | $1,040,000 |
| Cash Flow From Continuing Financing Activities | $140,712,000 | $63,824,000 | $173,830,000 | $1,040,000 |
| Net Other Financing Charges | $1,000 | $-239,000 | $-1,043,000 | - |
| Net Common Stock Issuance | $140,357,000 | $26,219,000 | $144,935,000 | $440,000 |
| Common Stock Issuance | $140,357,000 | $26,219,000 | $144,935,000 | $440,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $3,050,000 | $3,070,000 | $1,254,000 | - |
| Income Tax Paid Supplemental Data | $755,000 | $1,121,000 | $2,442,000 | - |
| End Cash Position | $149,987,000 | $165,470,000 | $220,638,000 | $143,381,000 |
| Beginning Cash Position | $165,470,000 | $220,638,000 | $143,381,000 | $273,347,000 |
| Effect Of Exchange Rate Changes | $1,045,000 | $194,000 | $867,000 | $-24,959,000 |
| Changes In Cash | $-16,528,000 | $-55,362,000 | $76,390,000 | $-105,007,000 |
| Proceeds From Stock Option Exercised | $354,000 | $37,844,000 | $353,000 | $600,000 |
| Change In Working Capital | $-14,249,000 | $11,723,000 | $3,483,000 | $-30,666,000 |
| Change In Other Working Capital | $23,000 | $686,000 | $-1,661,000 | $-1,701,000 |
| Change In Other Current Liabilities | $-2,452,000 | $-2,265,000 | $-1,959,000 | $-2,081,000 |
| Change In Payables And Accrued Expense | $-3,871,000 | $9,947,000 | $2,487,000 | $2,183,000 |
| Change In Accrued Expense | $-5,905,000 | $3,357,000 | $1,623,000 | $-314,000 |
| Change In Payable | $2,034,000 | $6,590,000 | $864,000 | $2,497,000 |
| Change In Account Payable | $2,034,000 | $6,590,000 | $864,000 | $2,497,000 |
| Change In Prepaid Assets | $-7,949,000 | $3,355,000 | $4,616,000 | $-29,067,000 |
| Other Non Cash Items | $9,656,000 | $3,708,000 | $2,663,000 | $2,126,000 |
| Stock Based Compensation | $13,590,000 | $19,517,000 | $17,277,000 | $13,123,000 |
| Depreciation Amortization Depletion | $216,000 | $233,000 | $242,000 | $330,000 |
| Depreciation And Amortization | $216,000 | $233,000 | $242,000 | $330,000 |
| Gain Loss On Investment Securities | $122,561,000 | - | - | - |
| Net Foreign Currency Exchange Gain Loss | $-1,152,000 | $755,000 | $-2,617,000 | $1,141,000 |
| Net Income From Continuing Operations | $-287,862,000 | $-155,122,000 | $-118,464,000 | $-91,505,000 |
| Issuance Of Debt | - | $0 | $29,585,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $29,585,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $29,585,000 | $0 |
| Long Term Debt Issuance | - | $0 | $29,585,000 | $0 |
| Net PPE Purchase And Sale | - | $0 | $-64,000 | $-596,000 |
| Sale Of PPE | - | $0 | $2,000 | $0 |
| Purchase Of PPE | - | $0 | $-66,000 | $-596,000 |
| Gain Loss On Sale Of PPE | - | $0 | $40,000 | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Change In Other Current Assets | - | - | - | $-307,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-15